CONTRACT FOR CARE · RIGHTS, CONSENT & GOVERNMENT POWER
Our Legal Case
A patient’s need for medicine should not become the pressure used to obtain a criminal admission. Examine compulsory disclosures, penalties for silence, coerced rights waivers, and the circumstances behind the signature.
Use the original agreement and policy sources for this record to identify the exact clause, its legal source, and the stated consequence. Preserve those facts before reaching a conclusion about a particular provider or condition.
Apply the constitutional and consent review to this record
- Government responsibility: Which law, binding rule, agency instruction, or public-provider policy requires the particular disclosure or consequence? Separate it from provider-added terms.
- Potential criminal admission: Identify the exact spoken answer, written history, certification, or explanation and the real criminal risk it creates.
- Penalty for silence: Record what happens if the patient invokes the privilege or refuses a rights waiver, including denial, discharge, or interruption of treatment.
- Consent and pressure: Preserve the circumstances of signing, severity of pain, accessible alternatives, and whether the patient could honestly accept the prospective obligations.
- Criminal-use protection: Identify legally sufficient immunity and limits on use of both the answer and evidence derived from it. A privacy assurance is a separate protection.
Read the precedents, evidence framework, clause review, and remedies and reform demands. The work develops a proposed constitutional challenge; applying it to a particular condition requires its facts and legal authority.
RHODE ISLAND · CONTRACT FOR CARE · DOCUMENT EVIDENCE
Comprehensive Pain Management — Controlled Substance Contract
Currently linked by the multi-state practice. Text identifies Franklin Pain and Wellness Center in Massachusetts. Use at Warwick or South Kingstown, and the version signed today, remain unconfirmed.
Version evidence: Printed revised May 2017. SA.
Read the complete original document · Practice’s document listing
State requirements and practice choices
The binding rule requires a signed written agreement in covered chronic-pain opioid treatment by 90 days (§4.4(F)); many possible clauses are discretionary. Patient education (§D), review (§G), and safe transition (§J) are separate duties. The 2026 statutory layer applies to its specified conditions. Scope and interaction with the regulation need individual review.
Source-located clause summaries
These are condensed paraphrases. Open the original for complete wording and context; page numbers count PDF pages. Classification identifies the source of a condition, not its enforceability.
| Location | Document requirement / consequence | Classification | Authority comparison |
|---|---|---|---|
| p1, bullets 1–2 | One Franklin prescriber and one pharmacy, including adjunctive analgesics. | Authorized / contemplated; discretionary | F(1)(c) contemplates limited prescribers; one-pharmacy rule remains a separate choice. |
| p1, bullets 3–4 | Up to 30-day supply; prescriptions changed only at scheduled visits. | Institution-specific policy | Six-month review rule does not prescribe this particular visit/refill restriction. |
| p1, bullets 5–7 | Use prescribed doses; no early refills in any circumstances. | Authorized / contemplated; discretionary | F(1)(a) permits a refill protocol, not this universal outcome. |
| p1, bullets 8–9 | No sharing/sales; secure storage; lost/stolen prescriptions not replaced. | Authorized / contemplated; discretionary | Safeguarding education is required by D; replacement protocol is discretionary. |
| p1, bullets 10–12 | Outside opioids/dose changes may cause discharge; report emergency or inpatient opioids within 24 hours. | Institution-specific policy | Specific notice deadline is practice language. |
| p1–2, pregnancy/addiction bullets | Report pregnancy within 24 hours and disclose substance/addiction history. | Institution-specific policy | Exact reporting deadline is not identified as a statewide requirement. |
| p2, alcohol bullet | Alcohol abstinence while taking narcotics. | Authorized / contemplated; discretionary | F(1)(d) contemplates alcohol/substance conditions; an all-alcohol prohibition is a practice implementation. |
| p2, screening bullet | Unannounced urine/blood testing; certain results trigger immediate discharge. | Unresolved / legal review | F(1)(f) contemplates random testing; interpretation and automatic discharge need review. |
| p2, pill-count bullet | Attend pill count within four hours; failure means immediate discharge. | Institution-specific policy | No four-hour deadline identified in controlling agreement rule. |
| p2, cost bullet | Patient pays screening charges insurance does not cover. | Institution-specific policy | Financial responsibility is separately stated by the practice. |
| p2, urine deadline | Complete requested urine screening within one hour or lose narcotics. | Institution-specific policy | Random-testing discretion does not establish a statewide one-hour deadline. |
| p2, containers/taper | Bring medication containers; comply with provider-directed taper. | Authorized / contemplated; discretionary | G permits consideration of taper/change/discontinuation; implementation and safe transition remain distinct. |
| p2, information bullets | Clinical sharing; confidentiality waived for authorities’ prescription-history questions. | Unresolved / legal review | Scope and enforceability of privacy authorization require separate review. |
| p2, final bullets | Violations permit discharge; some trigger no-notice dismissal; patient must find alternative care. | Unresolved / legal review | J imposes safe-transition duties when a long-term opioid patient is referred to another practitioner. |
Selected exact wording: “within a 4 hr time period” and “must be completed within 1 hour” (p2).
Refusal, noncompliance and continuity
Only consequences written in the located document are reported here. Actual enforcement and accommodations have not been independently established. These sources do not establish a separate consequence merely for refusing to sign. RIDOH’s June 10, 2015 guidance discusses context, clinical judgment and continuity; guidance and current binding rules remain separately labeled.
Update this evidence
Please identify current office use, replacement versions, exceptions and any factual correction. Privacy-waiver scope, dismissal and rapid taper language remain open for owner/legal review. No allegation of unlawful conduct or motive is made.
Rhode Island directory · Legal evidence library · Methodology
Reviewed: October 12, 2026.